Chief Operating Officer, Phibro Animal Health
Search every verified Larry Miller interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. In a September 2019 interview at VIV ASIA, Larry Miller, Chief Operating Officer of Phibro Animal Health, discussed the company's operations and product offerings. He stated that the company is "very heavily involved in the Asia-Pacific region" and operates globally in major livestock markets. Miller described the company's products as including medicated feed additives, nutrition specialty products for immune function and intestinal health, and a range of vaccines. He noted that the company services poultry, swine, aquaculture, and beef and dairy cattle. Miller highlighted several products featured at the event, including a new vaccine called MB1 for day-of-age chicks, an IB variant vaccine, and AVX Plus for controlling coccidiosis in poultry. He also mentioned Magnifide, a blend of natural products for enhancing immunity and gut health in broiler chickens. Miller said the company's customers include distributor customers and large livestock producers, and that the event provided an opportunity to align plans for growth with them. He added that the company aims to understand customers' unique challenges and bring solutions to address them.
“My name is Larry Miller I'm chief operating officer for Phibro Animal Health Corporation. Our company is very heavily involved in the Asia-Pacific region but we're also a global company operating in all major livestock markets.”
“We produce medicated feed additives which include antibiotics and anticoccidials. We also have nutrition specialty products that basically help with immune function and intestinal health and intestinal integrity, and we have a nice range of vaccines as well.”
“Our customers are first of all many of our distributor customers are here and this is always a great opportunity to meet with them and make sure that we've got our plans aligned with them and our future plans for growth with them.”
“We also have the opportunity to visit with a lot of large livestock producers, integrated food companies, particularly poultry companies. Many of those companies are also involved in aquaculture production and in swine production.”
“We have a new product that we're getting approved in many countries called MB1, which is a vaccine that can be used in hatcheries for day-of-age chicks. That's been one of the key vaccines that we featured.”
“AVX Plus is one of our key products; it's a combination product for controlling coccidiosis in poultry. Another new product is Magnifide, which is a blend of natural products used in poultry to control and enhance immunity and gut health.”
“We really spend every day trying to work with our customers, understand their needs, their unique challenges, and bring solutions that really help them address some of the challenges that they face.”
Sign in to search the full transcript archive, filter by topic, and access every quote from Larry Miller.
The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →